Searched for
MERCK ACQUISITION
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma to buy Organon in $11.75 billion all-cash dealSun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion,...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- Verona Pharma stock jumps 20% on $10B Merck deal—can FDA-approved Ohtuvayre reshape COPD care?Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...
- Merck nears $10 bn deal for respiratory drugmaker Verona: ReportsMerck is close to buying Verona Pharma, a biotech firm specializing in lung diseases. The deal is valued at around $10 billion. Merck aims ...
- Merck Ltd renamed as Procter & Gamble Health LtdThe consumer health business was transferred to P&G on December 1, 2018, it added.
- CCI approves P&G's stake acquisition in MerckThe global deal is for about 3.4 billion euro in cash.
- Merck to acquire SmartCells for USD 500 mnDrug-maker Merck & Co has announced that it will buy biotechnology company SmartCells for USD 500 million.
- Merck to take buyout route to grow hereThe world’s second-biggest drugmaker, Merck & Co, is looking at acquisitions and alliances with local firms to scale up its business in Ind...
- Drugmaker Merck closing 8 plants, 8 research sitesDrugmaker Merck & Co. said Thursday it is shutting down eight manufacturing plants and eight research sites around the world, including two...
- Merck KGaA acquires Bangalore-based bioscience companyMerck KGaA today announced the acquisition of Bangalore Genei (India) Private Limited by its wholly-owned subsidiary in India, Merck Specia...
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.
- Mylan Labs may use Indian platform for global pharma playWith the acquisition of Merck KGaA’s generic business by Mylan Laboratories, India is set to become a major manufacturing hub for the US dr...
- Ranbaxy sees synergy dose in Merck unitRanbaxy’s reported interest in the Merck KGaA’s generic division has the potential of being one of the most synergistic acquisitions in rec...
- Merck buy may give Ranbaxy access to US, Europe marketsRanbaxy Labs has joined the race with global pharma companies such as Teva, Novartis and Sanofi-Aventis for acquiring the global generic dr...
- Ranbaxy may pop Merck pillRanbaxy Labs has entered the race for acquiring the global generic drug business of Merck KGaA.
Load More
